Press Releases
Reliable partnership for timely drug approvals
Navigating the IND phase requires precision, expertise, and collaboration. Taeheui Lee, VP at Samsung Biologics, shares how CDMOs play a key role in accelerating drug development with tailored CMC strategies, scalable production, and expertise in regulatory compliance—all while ensuring safety and efficacy.
Discover how Samsung Biologics empowers drug developers with advanced technologies and a quality mindset to meet evolving industry demands.
Navigating the IND phase requires precision, expertise, and collaboration. Taeheui Lee, VP at Samsung Biologics, shares how CDMOs play a key role in accelerating drug development with tailored CMC strategies, scalable production, and expertise in regulatory compliance—all while ensuring safety and efficacy.
Discover how Samsung Biologics empowers drug developers with advanced technologies and a quality mindset to meet evolving industry demands.